Triple
T15982950
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Ariad Pharmaceuticals |
E387618
|
entity |
| Predicate | keyPerson |
P256
|
FINISHED |
| Object | Harvey J. Berger |
—
|
NE NERFINISHED |
Disambiguation candidates (1 decision)
The exact options the model was shown at each disambiguation step, with the option it chose highlighted — the evidence behind this triple's disambiguated ids.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Harvey J. Berger Context triple: [Ariad Pharmaceuticals, keyPerson, Harvey J. Berger]
-
A.
Harvey J. Berger
chosen
Harvey J. Berger is an American physician-scientist and biotechnology executive best known as the founder and longtime leader of Ariad Pharmaceuticals, a company focused on developing targeted cancer therapies.
-
B.
Frank E. Seidman
Frank E. Seidman was an influential figure in the field of political economy, honored by a distinguished award that bears his name.
-
C.
Bernard L. Nussbaum
Bernard L. Nussbaum is an American lawyer and television producer best known for his work as an executive producer on the legal drama series "Body of Proof."
-
D.
Sidney F. Brody
Sidney F. Brody was a prominent American art collector and philanthropist known for owning major modern artworks, including masterpieces by Pablo Picasso.
-
E.
Louis F. Edelman
Louis F. Edelman was an American film and television producer active in the mid-20th century, known for his work on notable crime and drama productions.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69d86da94ccc819083d187f5dc6a123e |
elicitation | completed |
| NER | batch_69e15755b5548190acfa29eecb11e675 |
ner | completed |
Created at: April 10, 2026, 4:54 a.m.